PathMaker Neurosystems

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, PathMaker Neurosystems sits in the upper quartile of US sponsors by registered trial count (#3,661 of 15,742 sponsors by registered trial count).

3 total trials 1 currently recruiting 1 completed upper quartile by trial count

PathMaker Neurosystems: 3 sponsored US clinical trials, 1 recruiting.

PathMaker Neurosystems sponsors 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 1 completed. The most-studied condition in this pipeline is ALS (Amyotrophic Lateral Sclerosis), with 1 trials.

Upper-quartile sponsor footprint

PathMaker Neurosystems sits in the upper quartile of the sponsor corpus (#3,661 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Open and recent trials

3 total, page 1 of 1

RECRUITING NA

Controlling Amyotrophic Lateral Sclerosis Motor Neuron Excitability Study

NCT06649955
COMPLETED NA

Early Feasibility Study of the MyoRegulator® for Treatment of ALS

NCT06165172
TERMINATED NA

Study Evaluating MyoRegulator® Treatment in Post-Stroke Upper Limb Spasticity

NCT04742257

Therapeutic Areas

ALS (Amyotrophic Lateral Sclerosis) 1

What is open in the PathMaker Neurosystems pipeline

1 recruiting of 3 indexed (33% open); 1 completed (33%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: ALS (Amyotrophic Lateral Sclerosis) (1 trial), 0 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

PathMaker Neurosystems: open-pipeline peers nationwide

Peers matched on 3 registered trials and 33% open enrollment, not the therapeutic-area sidebar.

PathMaker Neurosystems sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 246810 0%10%20%30%40% Total trials Recruiting share PathMaker Neurosystems10xBio22nd Century GroupAA SecordAAADRS Clinical Research CenterAadi BioscienceAaron CookAbivax S.A.Actuated Medical
PathMaker Neurosystems sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

PathMaker Neurosystems sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 3 trials (± recruiting share)

Sponsors near 33% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this PathMaker Neurosystems page

3 registered trials is a research-attention snapshot, not an endorsement of PathMaker Neurosystems or any single study.

  • 1 of PathMaker Neurosystems's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • ALS (Amyotrophic Lateral Sclerosis) is the condition PathMaker Neurosystems studies most, compare against other sponsors active in the same condition before evaluating a specific study. See ALS (Amyotrophic Lateral Sclerosis) trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

PathMaker Neurosystems pipeline card: 3 registered trials from official public datasets.Report a data error.